A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Pantep Angchaisuksiri; Wolfram Ruf; Jeffrey Weitz; Sam Schulman; Guy A. Young; Bianca Rocca; Emma C. Hansson; Milan Milojevic; Anders Jeppsson

doi:10.4081/btvb.2025.188

Correspondence

All Items

Letters to the Editor deliver information or news regarding an issue related to the Journal scope.
Commentaries are discussions of an article, either previously published in Bleeding, Thrombosis and Vascular Biology or in another journal, of sufficient interest to warrant further comment or explanation.

Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

https://doi.org/10.4081/btvb.2022.28

5203

PDF: 448

APPENDIX: 120

Thrombotic thrombocytopenic purpura: much done, but still a lot to do

Paola Binetti

https://doi.org/10.4081/btvb.2024.149

506

PDF: 173

The metaphor of Ukrainian science "bleeding"

Gaetano Torlone

https://doi.org/10.4081/btvb.2023.73

310

PDF: 178

The intriguing association between cancer and congenital bleeding disorders

Ezio Zanon

https://doi.org/10.4081/btvb.2024.146

191

PDF: 62

The diagnostic procedure for subjects with suspected pulmonary embolism. A recent comparison among the recommendations available from the international guidelines

Gualtiero Palareti

https://doi.org/10.4081/btvb.2024.122

890

PDF: 237

Supplementary Material: 37

The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research

Loredana Bury, Marco Malvestiti, Paolo Gresele

https://doi.org/10.4081/btvb.2024.159

926

PDF: 219

Synthetic platelets: can bioengineering realize in few years what evolution made in over 200 million years?

Paolo Gresele

https://doi.org/10.4081/btvb.2024.148

1807

PDF: 349

SISET50: trajectories of hemostasis and thrombosis in Italy 1970-2020

Giovanni de Gaetano, Maria Benedetta Donati, Americo Bonanni

https://doi.org/10.4081/btvb.2025.170

970

PDF: 203

Science and scientists under attack

Valerio De Stefano

https://doi.org/10.4081/btvb.2023.80

331

PDF: 154

ReDIP, the Italian network for the diagnosis of congenital platelet function disorders

Marco Cattaneo, Claudia Ghali, Mariangela Scavone

https://doi.org/10.4081/btvb.2024.134

357

PDF: 116

Platelet transcriptomic changes in myocardial infarction are sex and clinical subtype-related: a step forward towards precision medicine?

Loredana Bury, Alessio Branchini, Francesco Bernardi, Paolo Gresele

https://doi.org/10.4081/btvb.2025.173

254

PDF: 69

Palestinian patients associations appeal on World Hemophilia Day

Sara Mellano

https://doi.org/10.4081/btvb.2024.136

335

PDF: 97

How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Anna Falanga, Hugo Ten Cate, Bianca Rocca

https://doi.org/10.4081/btvb.2023.60

674

PDF: 299

Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”

Marco Marietta, Giancarlo Castaman

https://doi.org/10.4081/btvb.2025.180

751

PDF: 266

Comments on "Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial"

Jozef Vermylen

https://doi.org/10.4081/btvb.2024.162

592

PDF: 109

Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

Ottavia Borghese, Claudio Vincenzoni

https://doi.org/10.4081/btvb.2024.141

1004

PDF: 254

Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"

Vittorio Pengo

https://doi.org/10.4081/btvb.2025.179

195

PDF: 51

Author's Reply. Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

https://doi.org/10.4081/btvb.2024.163

543

PDF: 111

Artificial intelligence, platelets and aspirin

Giovanni de Gaetano

https://doi.org/10.4081/btvb.2024.130

396

PDF: 183

A contribution from Umberto Veronesi Foundation

Chiara Tonelli

https://doi.org/10.4081/btvb.2023.74

286

PDF: 138

A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Pantep Angchaisuksiri, Wolfram Ruf, Jeffrey Weitz, Sam Schulman, Guy A. Young

https://doi.org/10.4081/btvb.2025.188

171

PDF: 42

Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

https://doi.org/10.4081/btvb.2024.156

1382

PDF: 269

Appendix: 187

Correspondence

All Items

Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Thrombotic thrombocytopenic purpura: much done, but still a lot to do

The metaphor of Ukrainian science "bleeding"

The intriguing association between cancer and congenital bleeding disorders

The diagnostic procedure for subjects with suspected pulmonary embolism. A recent comparison among the recommendations available from the international guidelines

The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research

Synthetic platelets: can bioengineering realize in few years what evolution made in over 200 million years?

SISET50: trajectories of hemostasis and thrombosis in Italy 1970-2020

Science and scientists under attack

ReDIP, the Italian network for the diagnosis of congenital platelet function disorders

Platelet transcriptomic changes in myocardial infarction are sex and clinical subtype-related: a step forward towards precision medicine?

Palestinian patients associations appeal on World Hemophilia Day

How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”

Comments on "Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial"

Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"

Author's Reply. Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Artificial intelligence, platelets and aspirin

A contribution from Umberto Veronesi Foundation

A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

authors

reviewers

Categories

indexing

aice

Keywords